BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Genetic Polymorphisms and Cancer Susceptibility of Breast Cancer in Korean Women

  • Kang, Dae-Hee (Department of Preventive Medicine, Seoul National University College of Medicine)
  • Published : 2003.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Breast cancer is the most prevalent cancer among women in Western countries, and its prevalence is also increasing in Asia. The major risk factor for breast cancer can be traced to reproductive events that influence the lifetime levels of hormones. However, a large percentage of breast cancer cases cannot, be explained by these risk factors. The identification of susceptibility factors that predispose individuals to breast cancer (for instance, if they are exposed to particular environmental agents) could possibly give further insight into the etiology of this malignancy and provide targets for the future development of therapeutics. The most interesting candidate genes include those that mediate a range of functions. These include carcinogen metabolism, DNA repair, steroid hormone metabolism, signal transduction, and cell cycle control. We conducted a hospital-based case-control study in South Korea to evaluate the potential modifying role of the genetic polymorphisms of selected low penetrance genes that are involved in carcinogen metabolisms (i.e., CYP1A1, CYP2E1, GSTM1/T1/P1, NAT1/2, etc.), estrogen synthesis and metabolism (i.e., CYP19, CYP17, CYP1B1, COMT, ER-$\alpha$, etc.), DNA repair (i.e., XRCC1/3, ERCC2/4, ATM, AGT, etc.), and signal transduction as well as others (i.e., TGF-$\beta$, IGF-1, TNF-$\beta$, IL-1B, IL-1RN, etc.). We also took into account the potential interaction between these and the known risk factors of breast cancer. The results of selected genes will be presented in this mini-review.

Keywords

References

  1. Feigelson, H. S. and Henderson, B. E. (1996) Estrogens and breast cancer. Carcinogenesis 17, 2279-2284. https://doi.org/10.1093/carcin/17.11.2279
  2. Helzlsouer, K. J.. Selmin, O., Huang, H. Y., Strickland, P. T., Hoffman, S., Alberg, A. J., Watson, M., Comstock, G. W. and Bell, D. (1998) Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J. Natl. Cancer Inst. 90, 513-518.
  3. Kang, H. J., Kim, S. W., Ahn, S. J., Bae. J. Y., Park, S. K., Kang, D., Hirvonen, A., Choe, K. J. and Noh, D. Y. (2002) Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk. Cancer Lett. 178, 175-180. https://doi.org/10.1016/S0304-3835(01)00861-8
  4. Kim, S. U., Park, S. K., Yoo, K. Y., Yoon, K. S., Choi, J. Y., Noh, D. Y., Ahn, S. H., Choe, K. J., Strickland, P. T., Hirvonen, A and Kang, D. (2002) XRCC1 genetic polymorphism and breast cancer risk. Phamlacogenetics 12, 335-338. https://doi.org/10.1097/00008571-200206000-00010
  5. Park, S. K., Yoo, K. Y., Lee, S. J., Kim, S. U., Ahn, S. H., Noh, D. Y., Choe, K. J., Strickland, P. T., Hirvonen, A and Kang D. (2000) Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Phamwcogenetics 10, 1-9. https://doi.org/10.1097/00008571-200002000-00001
  6. Parkin, D. M., Whelan, S. L., Ferlay, J., Raymond, L., Young, J. (1997) Cancer Incidence in Five Continents, Vol VII, International Agency for Research on Cancer (IARC). Scientific Publications No. 143, Lyon.
  7. Shen, M. R., Jones, I. M. and Mohrenweiser, H. (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA genes in healthy humans. Cancer Res. 58, 604-608.
  8. Yager, J. D. and Liehr, J. G. (1996) Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacal. Toxieol. 36, 203-232 https://doi.org/10.1146/annurev.pa.36.040196.001223
  9. Yim, D. S., Park, S. K., Yoo, K. Y., Yoon, K. S., Chung, H. H., Ahn, S. H., Noh, D. Y, Choe, K. J., Jang, I. J., Shin, S. G., Strickland, P. T., Hirvonen, A. and Kang D. (2001) Relationship between the $Val^{158}$Met polymorphism of catechol O-methyl transferase and breast cancer. Pharmacogenetics 11, 279-286. https://doi.org/10.1097/00008571-200106000-00001
  10. Yoo, K. Y., Kang, D., Park, S. K., Kim, S. D., Shin, A. S., Yoon, H., Ahn, S. H., Noh, D. Y. and Choe, K. J. (2002) Epidemiology of breast cancer in Korea. Occurrence, high risk groups, and prevention. J. Korean Med. Sci. 17, 386-390
  11. Yu, Z., Chen, J., Ford, B. N., Brackley, M. E. and Glickman, B. W. (1999) Human DNA repair systems: an overview. Environ. Mol. Mutag. 33, 3-20. https://doi.org/10.1002/(SICI)1098-2280(1999)33:1<3::AID-EM2>3.0.CO;2-L
  12. Zhu, B. T. and Conney, A. H. (1998) Functional role of estrogen metabolism in target cells; review and perspectives. Carcinogenesis 12, 1-27.

Cited by

  1. SNP-SNP interactions in breast cancer susceptibility vol.6, pp.1, 2006, https://doi.org/10.1186/1471-2407-6-114
  2. Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis vol.7, pp.1, 2012, https://doi.org/10.1186/1746-1596-7-136
  3. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis vol.122, pp.2, 2010, https://doi.org/10.1007/s10549-009-0694-5
  4. Induction of CYP1A1 and CYP1B1 and formation of carcinogen–DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene vol.221, pp.2, 2005, https://doi.org/10.1016/j.canlet.2004.08.038
  5. Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: A meta-analysis involving 16,703 individuals vol.56, pp.2, 2011, https://doi.org/10.1016/j.cyto.2011.06.018
  6. Genetic Polymorphism of XRCC1 Correlated with Response to Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer vol.18, pp.4, 2012, https://doi.org/10.1007/s12253-012-9536-6
  7. Breast Cancer Screening for Korean Women Must Consider Traditional Risks as well as Two Genetic Risk Factors vol.30, pp.3, 2007, https://doi.org/10.1097/01.NCC.0000270705.41919.dc
  8. Combined effect of menopause age and genotype on occurrence of breast cancer risk in Pakistani population vol.69, pp.4, 2011, https://doi.org/10.1016/j.maturitas.2011.05.008
  9. Current researches on breast cancer epidemiology in Korea vol.10, pp.4, 2003, https://doi.org/10.1007/BF02967647
  10. Genetic polymorphism of ESR1 rs2881766 increases breast cancer risk in Korean women vol.141, pp.4, 2015, https://doi.org/10.1007/s00432-014-1849-2
  11. Possible Risk Modification by Polymorphisms of Estrogen Metabolizing Genes in Familial Breast Cancer Susceptibility in an Indian Population vol.28, pp.3, 2010, https://doi.org/10.3109/07357900902744494
  12. Gene polymorphisms in bladder cancer vol.26, pp.1, 2008, https://doi.org/10.1016/j.urolonc.2006.10.011
  13. CYP1A1 and GSTM1/T1 Genetic Variation in Predicting Risk for Cerebral Infarction vol.32, pp.2, 2007, https://doi.org/10.1007/s12031-007-0028-1
  14. Haplotype analysis of XRCC1 (at codons 194 and 399) and susceptibility to breast cancer, a meta-analysis of the literatures vol.124, pp.3, 2010, https://doi.org/10.1007/s10549-010-0895-y
  15. Genetic variants as potential predictive biomarkers in advanced colorectal cancer patients treated with oxaliplatin-based chemotherapy 2018, https://doi.org/10.1002/jcp.25966
  16. Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario vol.5, pp.1, 2007, https://doi.org/10.1186/1741-7015-5-22
  17. The Polymorphism of DNA Repair Gene ERCC2/XPD Arg156Arg and Susceptibility to Breast Cancer in a Chinese Population vol.47, pp.7-8, 2009, https://doi.org/10.1007/s10528-009-9246-2
  18. Influence of the CYP17 polymorphism on vasomotor symptoms in postmenopausal women: a pilot study vol.14, pp.5, 2011, https://doi.org/10.3109/13697137.2010.548668
  19. RETRACTED: Genetic Polymorphism of XRCC1 Correlated with Response to Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer vol.31, pp.1, 2013, https://doi.org/10.3109/07357907.2012.716468
  20. Genetic losses in breast cancer: toward an integrated molecular cytogenetic map vol.160, pp.2, 2005, https://doi.org/10.1016/j.cancergencyto.2004.12.018
  21. Estrogen Receptor α Gene Polymorphism and Breast Cancer vol.1138, pp.1, 2008, https://doi.org/10.1196/annals.1414.015
  22. Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis vol.122, pp.2, 2010, https://doi.org/10.1007/s10549-009-0728-z
  23. Polymorphisms of the DNA polymerase β gene in breast cancer vol.103, pp.2, 2007, https://doi.org/10.1007/s10549-006-9357-y
  24. Commonly Studied Single-Nucleotide Polymorphisms and Breast Cancer: Results From the Breast Cancer Association Consortium vol.98, pp.19, 2006, https://doi.org/10.1093/jnci/djj374
  25. XRCC3 Thr241Met polymorphism and breast cancer risk: a meta-analysis vol.121, pp.2, 2010, https://doi.org/10.1007/s10549-009-0562-3